HIV peptides from conserved in gag p17 and 924 and their application in E.G. vaccines

Details for Australian Patent Application No. 2001282706 (hide)

Owner Bionor Immuno AS

Inventors Sorensen, Birger

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001282706

PCT Pub. Number WO02/20554

Priority 20004413 04.09.00 NO

Filing date 3 September 2001

Wipo publication date 22 March 2002

Acceptance publication date 22 March 2007

International Classifications

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 March 2007 Application Accepted

  Published as AU-B-2001282706

19 July 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001282707-The use of honey in wound dressings

2001282705